Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23967662 | 0.87 | CYP1A2 (0.38) | CYP1A2CYP2A6 | |
| SCHEMBL20172802 | 0.86 | ACHE (0.37) | CYP1A2CYP2A6NPC1RAB9A | |
| SCHEMBL20650814 | 0.85 | CYP1A2 (0.31) | CYP1A2CYP2A6NPC1RAB9A | |
| SCHEMBL21020293 | 0.83 | NR1H2 (0.34) | — | |
| SCHEMBL21021478 | 0.83 | CYP1A2 (0.31) | CYP1A2CYP2A6 | |
| SCHEMBL21020264 | 0.82 | LMNA (0.39) | NPC1RAB9A | |
| SCHEMBL21020285 | 0.82 | MEN1 (0.30) | CYP1A2CYP2A6 | |
| SCHEMBL21021455 | 0.82 | MEN1 (0.36) | NPC1 | |
| SCHEMBL21020274 | 0.82 | LMNA (0.33) | CYP1A2CYP2A6 | |
| SCHEMBL20172817 | 0.81 | NPC1 (0.34) | NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3428152-B1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2021-11-03 | — | — | EP | disclosed |
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, ESR1 | CYP1A2 563/4885CYP2A6 433/4885NPC1 1478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.